
Woodline Partners LP
About Woodline Partners LP’s 13F portfolio
Woodline Partners LP is an institutional investment manager that discloses its US-listed holdings each quarter through an SEC Form 13F filing. As of , Woodline Partners LP reported $32.4B across 1,011 US-listed positions (). Its largest position is NVIDIA CORPORATION (NVDA) at 3.3% of the reported book, and its ten biggest holdings make up 17% of the portfolio. Browse every manager in the fund managers directory, or see the legendary investors we track on the superinvestors page.
| # | Stock | Price | % of portfolio | Shares | Value |
|---|---|---|---|---|---|
| 1 | NASDAQ: NVDA NVIDIA CORPORATION | — — | 3.3% | 5.4M | $1.1B |
| 2 | NASDAQ: AAPL APPLE INC | — — | 2.9% | 3.2M | $927.5M |
| 3 | NASDAQ: MSFT MICROSOFT CORP | — — | 1.9% | 1.6M | $606.8M |
| 4 | NASDAQ: AMZN AMAZON COM INC | — — | 1.8% | 2.5M | $588.4M |
| 5 | NASDAQ: META META PLATFORMS INC | — — | 1.4% | 823K | $463.3M |
| 6 | NASDAQ: AVGO BROADCOM INC | — — | 1.4% | 1.2M | $444.5M |
| 7 | NASDAQ: GOOGL ALPHABET INC | — — | 1.2% | 1.1M | $396.4M |
| 8 | NASDAQ: RVMD REVOLUTION MEDICINES INC | — — | 1.2% | 2.0M | $375.1M |
| 9 | NASDAQ: GOOG ALPHABET INC | — — | 1.1% | 1.0M | $362.4M |
| 10 | NASDAQ: MU MICRON TECHNOLOGY INC | — — | 1.0% | 275K | $317.1M |
| 11 | NYSE: LLY ELI LILLY & CO | — — | 0.9% | 245K | $293.7M |
| 12 | NASDAQ: TSLA TESLA INC | — — | 0.8% | 642K | $270.2M |
| 13 | NYSE: JNJ JOHNSON & JOHNSON | — — | 0.8% | 1.1M | $266.8M |
| 14 | NYSE: VZ VERIZON COMMUNICATIONS INC | — — | 0.8% | 6.0M | $256.0M |
| 15 | NASDAQ: MCHP MICROCHIP TECHNOLOGY INC. | — — | 0.7% | 2.6M | $241.7M |
| 16 | NYSE: ABBV ABBVIE INC | — — | 0.7% | 907K | $228.3M |
| 17 | NYSE: PM PHILIP MORRIS INTL INC | — — | 0.7% | 1.2M | $215.3M |
| 18 | NYSE: PGR PROGRESSIVE CORP | — — | 0.6% | 938K | $204.9M |
| 19 | NYSE: ARW ARROW ELECTRS INC | — — | 0.6% | 908K | $193.8M |
| 20 | NYSE: JPM JPMORGAN CHASE & CO | — — | 0.6% | 585K | $191.5M |
| 21 | NASDAQ: LITE LUMENTUM HLDGS INC | — — | 0.6% | 221K | $189.3M |
| 22 | NASDAQ: AMD ADVANCED MICRO DEVICES INC | — — | 0.6% | 325K | $188.9M |
| 23 | BRK/B BERKSHIRE HATHAWAY INC DEL | — — | 0.6% | 375K | $187.6M |
| 24 | NASDAQ: PTGX PROTAGONIST THERAPEUTICS INC | — — | 0.5% | 1.4M | $173.3M |
| 25 | NASDAQ: LRCX LAM RESEARCH CORP | — — | 0.5% | 387K | $167.7M |
Showing 1–25 of 500 positions on this page — of 1,011 total reported in this 13F. Positions beyond the first 500 are not yet available on this page.
- Technology24%
- Healthcare23%
- Financial Services9.4%
- Consumer Cyclical8.8%
- Communication Services7.4%
- Industrials6.5%
- Consumer Defensive3.7%
- Real Estate3.2%
- Basic Materials2.8%
- Energy1.1%
- Utilities0.7%
- AddedNVDANVIDIA CORPORATION+12.2%$1.1B
- AddedAAPLAPPLE INC+11.4%$927.5M
- AddedMSFTMICROSOFT CORP+15.2%$606.8M
- AddedMETAMETA PLATFORMS INC+108%$463.3M
- AddedAVGOBROADCOM INC+29.9%$444.5M
- AddedGOOGALPHABET INC+11.1%$362.4M
- AddedLLYELI LILLY & CO+6.2%$293.7M
- AddedTSLATESLA INC+18.6%$270.2M
- AddedVZVERIZON COMMUNICATIONS INC+25.0%$256.0M
- AddedMCHPMICROCHIP TECHNOLOGY INC.+641%$241.7M
- ReducedAMZNAMAZON COM INC−8.6%$588.4M
- ReducedGOOGLALPHABET INC−22.6%$396.4M
- ReducedRVMDREVOLUTION MEDICINES INC−20.1%$375.1M
- ReducedMUMICRON TECHNOLOGY INC−15.7%$317.1M
- ReducedJNJJOHNSON & JOHNSON−31.2%$266.8M
- ReducedARWARROW ELECTRS INC−16.0%$193.8M
- ReducedAMDADVANCED MICRO DEVICES INC−7.6%$188.9M
- ReducedSTSENSATA TECHNOLOGIES HLDG PL−11.3%$164.8M
- ReducedTMOTHERMO FISHER SCIENTIFIC INC−6.4%$158.6M
- ReducedAMATAPPLIED MATLS INC−63.1%$151.0M
Companies where this manager has disclosed a stake of more than 5% of a class of shares, as reported to the SEC on Schedule 13D (activist) or 13G (passive). Figures are as disclosed in each filing — tap a date to open the source document.
| # | Stock | Type | % of class | Shares | Filed |
|---|---|---|---|---|---|
| 1 | SABS SAB Biotherapeutics, Inc. | 13G | 9.9% · 2 classes | 7.1M | Filed 14 NOV 2025 |
| 2 | AIRO AIRO Group Holdings, Inc. | 13G | 8.5% | 2.8M | Filed 14 NOV 2025 |
| 3 | TNGX Tango Therapeutics, Inc. | 13G | 7.5% | 10.1M | Filed 17 FEB 2026 |
| 4 | OKYO OKYO Pharma LTD | 13G | 7.0% | 3.7M | Filed 15 MAY 2026 |
| 5 | XOMA XOMA Royalty Corp | 13G | 5.4% | 640K | Filed 15 MAY 2026 |
| 6 | ALGS Aligos Therapeutics, Inc. | 13G | 5.4% | 289K | Filed 17 FEB 2026 |
| 7 | FWRG First Watch Restaurant Group, Inc. | 13G | 5.3% | 3.3M | Filed 16 NOV 2026 |
| 8 | BHVN Biohaven Ltd. | 13G | 5.1% | 7.7M | Filed 14 AUG 2026 |
Showing all 8 disclosed stakes.
Reading Woodline Partners LP’s 13F portfolio
Woodline Partners LP’s $32.4B 13F book is spread across 1,011 reported positions and is broadly diversified — the ten largest names are just 17% of the portfolio. Spread this wide across 1,011 names, no single position dominates, which is typical of large, index-oriented mandates that track broad market exposure. Its five largest positions are NVDA, AAPL, MSFT, AMZN and META, led by NVIDIA CORPORATION (NVDA) at 3.3% of the portfolio. The heaviest sector exposure is Technology (24%), then Healthcare (23%).
What Woodline Partners LP changed last quarter
Between 2026-03-31 and Q2 2026, Woodline Partners LP was a net buyer: it opened 170 new positions and added to 543 more, while trimming 214 and closing 181 outright. Against a 1,011-name book, that is high turnover, pointing to an active reshuffle of the book. Its largest new or increased position was NVIDIA CORPORATION (NVDA), and its biggest reduction was AMAZON COM INC (AMZN).
What a 13F does and doesn’t reveal
A 13F captures only Woodline Partners LP’s long positions in US-listed stocks at a single quarter-end, so it is best read as a lagged snapshot rather than a live portfolio. It won’t show shorts, cash, bonds, or holdings listed outside the US, and it never reveals the price paid or the reasoning behind a trade. The signal is in the pattern over time: which names Woodline Partners LP is building up, trimming, or exiting, and how concentrated the book stays from quarter to quarter.
Frequently asked questions
What is an SEC 13F filing?
A Form 13F is a report that every institutional investment manager with at least $100 million in US-listed securities must file with the SEC within 45 days of each quarter's end. It lists the manager's long positions in US-listed stocks and certain options, with the share count and market value of each. Woodline Partners LP's profile on this page is built directly from those filings.
How current is the 13F data on Woodline Partners LP's page?
It reflects Woodline Partners LP's most recently filed 13F, currently the quarter ending Q2 2026. Because managers have up to 45 days after a quarter closes to file, a 13F is always a slightly lagged view rather than a live portfolio. When Woodline Partners LP files its next quarterly report, this page refreshes automatically.
Can I see Woodline Partners LP's complete list of holdings?
This page highlights Woodline Partners LP's largest positions rather than all 1,011 names in the filing. The complete, position-by-position 13F is public and available from the SEC's EDGAR database under Woodline Partners LP's filings.
Does a 13F show everything Woodline Partners LP owns?
No. A 13F only covers long positions in US-listed stocks and certain options. It leaves out short positions, cash, bonds, commodities, foreign-listed stocks, and private holdings, so it is a partial view of Woodline Partners LP's book rather than its full strategy or total assets.
Is 13F data investment advice?
No. Everything here is educational. 13F positions are disclosed with a delay, cover only long US-listed holdings, and never explain why Woodline Partners LP made a trade or at what price. Treat it as a research lens, not a recommendation, and speak with a licensed financial advisor before making investment decisions.
Not investment advice. Holdings data comes from public SEC Form 13F filings, which are filed with a delay of up to 45 days and may be amended later. It describes historical, disclosed positions in US-listed securities only, meaning no shorts, cash, or foreign holdings, and it is not a recommendation. Always do your own research and speak with a licensed financial advisor before making investment decisions.

